Inspire Medical Systems Inc (INSP) 13F Ownership Report (Q2 2026)

INSP ranks #2287 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

INSP is a disclosed holding of Cliff Asness (AQR Capital Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

277 institutions disclose a position in INSP, but none treat it as a major bet — even Soleus Capital Management, L.P., its most concentrated holder, allocates just 3.0% of its own portfolio to it.

Cliff Asness has added to its INSP position for two straight quarters, increasing it by $78.4M to reach $80.9M today.

Wellington Management Group LLP has trimmed its INSP position for two straight quarters, cutting it by $97.6M while still holding $106.3M.

INSP is up 2.5% today, and institutions have been net buyers of $358.5M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

INSP posted net income of $135.0M over the trailing twelve months, and currently trades at a P/E of 13.9.

• Profitable — net income of $135.0M over the trailing twelve months
• Revenue grew 4.3% year over year
• Net income improved year over year, from $53.1M to $135.0M
• Generated $117.0M in positive operating cash flow
• Current ratio of 6.08x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.16x equity — within a conventional range